Perfil
Akihiro Furuta is currently the President & Representative Director at AskAt, Inc. Previously, he worked as the Director, Senior Head-Personnel & Operations at RaQualia Pharma, Inc. from 2012 to 2014.
He obtained his undergraduate degree from Oberlin College and Nagoya University.
Cargos activos de Akihiro Furuta
| Empresas | Cargo | Inicio |
|---|---|---|
AskAt, Inc.
 AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Presidente | - |
Antiguos cargos conocidos de Akihiro Furuta.
| Empresas | Cargo | Fin |
|---|---|---|
| RAQUALIA PHARMA INC. | Director Técnico/Científico/I+D | 08/06/2012 |
Formación de Akihiro Furuta.
| Nagoya University | Undergraduate Degree |
| Oberlin College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| RAQUALIA PHARMA INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Health Technology |
- Bolsa de valores
- Insiders
- Akihiro Furuta
